Merck & Co., Inc. filed a Form 8-K on November 18, 2026, disclosing that board director Thomas H. Glocer gave notice on November 16, 2026, of his intention to retire from the company's Board of Directors at the 2027 Annual Meeting of Shareholders.
Key Highlights
- Notice date: Thomas H. Glocer gave notice of his retirement intention on November 16, 2026.
- Effective date: Glocer's retirement from the Board is set to take effect as of the company's 2027 Annual Meeting of Shareholders.
- No disagreement: According to the filing, the retirement "is not due to any disagreement with the Company with respect to any matter relating to the Company's operations, policies or practices."
- Exchange listings: Merck's common stock trades on the New York Stock Exchange under the symbol MRK, alongside several listed debt securities.
- Signing officer: The filing was signed by Kelly E. W. Grez, Corporate Secretary of Merck & Co., Inc.
Glocer's Planned Departure from Merck's Board of Directors
Merck & Co., Inc. (NYSE:MRK) reported under Item 5.02 of its Form 8-K that Thomas H. Glocer notified the company on November 16, 2026, of his plan to retire from the Board of Directors. According to the filing, the retirement will become effective at the time of the company's 2027 Annual Meeting of Shareholders, though no specific date for that meeting is provided in the disclosure.
The filing expressly states that Glocer's retirement "is not due to any disagreement with the Company with respect to any matter relating to the Company's operations, policies or practices." This language is a standard disclosure requirement under Item 5.02(b) of Form 8-K when a director departs before the expiration of their term. The filing does not provide additional details regarding the circumstances of the retirement or any plans to replace Glocer on the Board.
The 8-K was filed on November 18, 2026, two days after Glocer's notice, and was signed by Kelly E. W. Grez in her capacity as Corporate Secretary. An accompanying press release, identified as Exhibit 99.1 and dated November 18, 2026, was included with the filing, though its contents are not reproduced in the extracted text provided.
What Was Disclosed
Merck & Co., Inc. disclosed the planned retirement of board director Thomas H. Glocer, effective at the 2027 Annual Meeting of Shareholders, following notice given November 16, 2026. The company stated the departure involves no disagreement over operations, policies, or practices.





Please wait processing your request...